Draft:SiewNg/sandbox
| Submission declined on 25 June 2025 by Dan arndt (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: Wikipedia does not support the posting of personal autobiographies - clearly WP:SELFPROMOTION Dan arndt (talk) 04:35, 25 June 2025 (UTC)
Siew C. Ng
Siew C. Ng is a Hong Kong-based clinician-scientist and Croucher Professor in Medical Sciences at The Chinese University of Hong Kong, recognized for her contributions to inflammatory bowel disease (IBD) and gut microbiota research.[1][2] She has coordinated international studies on IBD epidemiology across the Asia-Pacific region and published over 400 articles in journals such as Nature and The Lancet.[3][4] Ng has been named a Highly Cited Researcher by Clarivate annually since 2020 and was elected a Foreign Member of Academia Europaea in 2024.[5]
Education
Siew C. Ng earned her Bachelor of Medicine and Surgery (MBBS) degree from St Bartholomew’s and the Royal London School of Medicine and Dentistry in 2000.[6][7] She completed a Doctor of Philosophy (PhD) degree at Imperial College London in 2009.[8]
Career
Ng joined The Chinese University of Hong Kong (CUHK) in 2010, where she serves as Croucher Professor in Medical Sciences and Associate Dean (Research) of the Faculty of Medicine.[9] She directs the Microbiota I-Center (MagIC), a research hub focused on microbiome-based therapeutics for diseases such as IBD and autism.[10][11] Ng has led research networks across the Asia-Pacific region, collaborating with institutions in over 20 countries to study IBD epidemiology and genetics, including the Asia-Pacific Crohn’s and Colitis Epidemiology Study (ACCESS).[12][13]
Research
Ng’s research focuses on inflammatory bowel disease (IBD), gut microbiota, and microbial therapeutics, including fecal microbiota transplantation.[14] Her work has advanced understanding of IBD epidemiology in Asia, where incidence has risen significantly.[15][16] She has also explored microbiome applications in autism spectrum disorder, identifying microbial markers for potential diagnostic tools,[17][18] colorectal cancer,[19] and post-acute COVID-19 syndrome, contributing to clinical approaches for long COVID.[20]
Awards and recognition
Ng was elected a Foreign Member of Academia Europaea in 2024.[21] In 2024, she received the Bank of China Hong Kong Science and Technology Innovation Prize in the Health for Life category.[22] In October 2023, she was selected as a New Cornerstone Investigator in Biology and Biomedical Sciences, the first Hong Kong scholar in this field to receive the honor.[23][24] Ng has been named a Highly Cited Researcher by Clarivate annually since 2020.[25]
References
- ^ "Ng Siew Chien". Croucher Foundation. Retrieved 2025-06-24.
- ^ "Hong Kong warned of surge in inflammatory bowel disease rates". South China Morning Post. 2025-05-26. Retrieved 2025-06-24.
- ^ Hracs, L.; Ng, S.C. (2025). "Global evolution of inflammatory bowel disease across epidemiologic stages". Nature. 642 (8067): 458–466. doi:10.1038/s41586-025-08940-0. PMC 12158780. PMID 40307548.
- ^ Ng, S.C. (2017). "Inflammatory bowel disease in Asia: a second chance at uncovering environmental factors". The Lancet. doi:10.1016/S0140-6736(17)32448-0. PMID 29050646.
- ^ "Ng, Siew C". Clarivate. Retrieved 2025-06-24."Ng, Siew Chien". Academia Europaea. Retrieved 2025-06-24.
- ^ "Professor Ng Siew Chien". The Chinese University of Hong Kong. Retrieved 2025-06-24.
- ^ "Hong Kong ranks third for new cases of bowel disease in Asia: researchers". South China Morning Post. 2017-10-17. Retrieved 2025-06-24.
- ^ "Ng Siew Chien". Croucher Foundation. Retrieved 2025-06-24.
- ^ "Professor Ng Siew Chien". The Chinese University of Hong Kong. Retrieved 2025-06-24.
- ^ "CUHK establishes Microbiota I-Center to advance microbiome research". Hong Kong Economic Times. 2021-11-09. Retrieved 2025-06-24.
- ^ "CUHK launches Microbiota I-Center (MagIC) to advance human health through innovative translational research in microbiome". The Chinese University of Hong Kong. 2021-11-10. Retrieved 2025-06-24.
- ^ "Hong Kong and Macau Among Top Three Regions in Asia with the Highest Incidence of Inflammatory Bowel Disease". The Chinese University of Hong Kong. 2013-09-11. Retrieved 2025-06-24.
- ^ Ran, Z.; Ng, S.C. (2021). "Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia". Journal of Gastroenterology and Hepatology. 36 (3): 637–645. doi:10.1111/jgh.15176. PMID 32633423.
- ^ "Hong Kong warned of surge in inflammatory bowel disease rates". South China Morning Post. 2025-05-26. Retrieved 2025-06-24.
- ^ "Hong Kong warned of surge in inflammatory bowel disease rates". South China Morning Post. 2025-05-26. Retrieved 2025-06-24.
- ^ "Global study maps the spread of IBD in Africa, Asia, and Latin America". News-Medical.net. 2025-05-29. Retrieved 2025-06-24.
- ^ Su, Q.; Ng, S.C. (2024). "Multikingdom and functional gut microbiota markers for autism spectrum disorder". Nature Microbiology. 9 (9): 2344–2355. doi:10.1038/s41564-024-01739-1. PMID 38977906.
- ^ Lee, K.S.; Ng, S.C. (2023). "Systematic review of gut microbiota and autism spectrum disorder". Frontiers in Psychiatry. doi:10.3389/fpsyt.2023.1238976 (inactive 25 June 2025).
{{cite journal}}: CS1 maint: DOI inactive as of June 2025 (link) - ^ Chan, F.K.L.; Ng, S.C. (2023). "Joint APAGE-APSDE guidelines on non-invasive biomarkers for colorectal neoplasia". Gut. doi:10.1136/gutjnl-2023-329805 (inactive 25 June 2025).
{{cite journal}}: CS1 maint: DOI inactive as of June 2025 (link) - ^ Lau, R.I.; Ng, S.C. (2024). "A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong". The Lancet Infectious Diseases. 24 (3): 256–265. doi:10.1016/S1473-3099(23)00685-0.
- ^ "Ng, Siew Chien". Academia Europaea. Retrieved 2025-06-24.
- ^ "Ng Siew Chien – 2024". Hong Kong Science and Technology Innovation Prize. Retrieved 2025-06-24.
- ^ "New Cornerstone Investigator Program". New Cornerstone Science Foundation. Retrieved 2025-06-24.
- ^ "CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong to be selected as a New Cornerstone Investigator". The Chinese University of Hong Kong. 2023-11-07. Retrieved 2025-06-24.
- ^ "Ng, Siew C". Clarivate. Retrieved 2025-06-24.